The Phase 1b/2a study will assess the safety of CNP-103 in adults (aged 18-35) and pediatrics (aged 12-17) who have Stage III or newly diagnosed (within the last 6 months) T1D as well as C-peptide ...
The student, who was a type 1 diabetic, was experiencing symptoms of diabetic ketoacidosis (DKA) approximately two weeks into the trip. Lachlan Cook, 16, who was a Type 1 diabetic, died on a ...